-
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial
Ulas, E. B., Purcell, N. D., Houda, I., Hashemi, S. M. S., Veltman, J., Daniels, J. M. A., Fransen, M. F., Radonic, T., Beeloo, L. R., van Rossum, P. S. N., van Maldegem, F., Barlo, N., Disselhorst, M., van Laren, M., Tiemessen, M. A., Tarasevych, S., van Haarst, J. M., van Tilburg, P., Kunst, P. W. A. & Moons-Pasic, A. & 7 others, , 22 Jun 2026, In: Journal for Immunotherapy of Cancer. 14, 6Research output: Contribution to Journal › Article › Academic › peer-review
-
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer
Lanser, D. A. C., Heersche, N., Muntinghe-Wagenaar, M. B., Ali, M. I. M., Ulas, E. B., de Jonge, E., Hoop, E.O.-D., Paats, M. S., Bahce, I., Croes, S., Langen, A. J., Hendriks, L. E. L., Wekken, A. J., Huitema, A. D. R., Schaik, R. H. N., Dingemans, A.-M. C., Veerman, G. D. M. & Mathijssen, R. H. J., 2026, In: Cancer Communications. 46, p. 31 1 p.Research output: Contribution to Journal › Comment / Letter to the editor › Academic
-
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC
Ulas, E. B., Koomen, S. J. I., Vrijmoet, A., Houda, I., Korkmaz, H. I., Dickhoff, C., Bahce, I., Senan, S., de Gruijl, T. D., Fransen, M. F., Radonic, T., van Maldegem, F. & Schneiders, F. L., 28 Nov 2025, In: Journal for Immunotherapy of Cancer. 13, 11, e013237.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
